Skip to main content

Table 1 Socio-economic characteristics, costs distributions, and treatment duration of children with leukemia

From: Disparities in economic burden for children with leukemia insured by resident basic medical insurance: evidence from real-world data 2015–2019 in Guangdong, China

Variables Code Freq. (%) Variables Code Value
Demographic information Total Costs & reimbursement (CNY/%)
Leukemia Type ALL 596(77.9%) Total Cost Median 244,250.1
AML 111(14.5%) IQR 156,330.8–357,847.4
Transplantation 58(7.6%) Total OOP Median 182,860.2
Hospitals Nanfang H 469(61.3%) IQR 112,324.1–266,849.7
Zhujiang H 296(38.7%) Total Reimbursement Median 47,575.45
Insurance Type GZ-RBMI 75(9.8%) IQR 0.00–115,375.0
GD-contracted 412(53.9%) RR Median 24.16
GD-uncontracted 60(7.8%) IQR 0.00–39.74
Other-contracted 38(5.0%)  
Other-uncontracted 46(6.0%) Cost structures (CNY)
OOP 134(17.5%) Operation/Procedure Median 481.59
Year 2015 212(27.7%) IQR 286.00–867.59
2016 147(19.2%) Simple Treatment Median 0.00
2017 170(22.2%) IQR 0.00–0.00
2018 144(18.8%) Blood Products Median 12,095.00
2019 92(12.0%) IQR 5760.00–24,125.00
Sex Male 482(63.0%) Drug Median 91,486.07
Female 283(37.0%) IQR 44,721.65–152,689.1
Age 0–5 419(54.8%)  
6–10 190(24.8%) Treatment Duration (Days)
11–15 156(20.4%) Total Treatment Duration Median 526.00
Region GD-PRD 261(34.1%) IQR 319.00–764.50
GD-Other 349(45.6%)  
Outside GD 155(20.3%) Total Inpatient Days Median 164.00
Hukou Urban 347(45.4%) IQR 126.00–213.50
  Rural 418(54.6%)  
  1. Transplantation, the AML patients who received transplantation. GD-PRD, the Pear-River Delta cities in Guangdong Province. GD-Other, the other cities in Guangdong outside Pear-River Delta regions
  2. RR reimbursement rate, CNY Chinese Yuan, IQR interquartile range, OOP out-of-pocket payment, ALL acute lymphoblastic leukemia, AML acute myeloid leukemia